How AI Is Shaping FDA Medical Device Regulation

By Ben Haas and Elizabeth Richards (October 15, 2019, 5:08 PM EDT) -- The U.S. Food and Drug Administration is focusing its efforts on modernizing the regulatory pathway to market new medical device products to account for artificial intelligence and machine learning. In addition, the FDA is looking at real-world evidence and how it may be utilized for regulatory purposes. The FDA has acknowledged that both artificial intelligence and real-world evidence will have a major impact on the future of health care, and the agency wants to ensure its policies don't delay innovative new treatment options for patients....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!